Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Thrombin inhibitors from Akzo Nobel

June 27, 1997

Orally active antithrombotic agents described by Pfizer

June 27, 1997

S.c. lepirudin vs. i.v. heparin for deep vein thrombosis

June 23, 1997

NicOx reveals antiinflammatory/antithrombotic compounds with low toxicity

June 20, 1997

RPR seeks approval for enoxaparin for unstable angina in Europe

June 18, 1997

3-Dimensional Pharmaceuticals licenses thrombin inhibitors to Wyeth-Ayerst

June 17, 1997

Chimeric molecule shows promise as thrombolytic therapy

June 11, 1997

Thomae prepares fibrinogen receptor antagonists

June 11, 1997

Novel fibrinogen antagonist from Merck & Co.

June 11, 1997

Thrombin inhibitors revealed by Merck & Co.

June 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...